Our Website Uses Cookies. We and third parties we work with use cookies to collect information about your internet browsing activities to provide you relevant content and advertising on this and other websites, media and devices you use, and to understand your interests to improve the site. For more information on our use of cookies, please view our full Privacy Statement. Click "OK" to continue.

Young boy on bicycle with older man at the beach

Savings offers

As part of Olumiant Together, you may be eligible to save on the cost of your treatment if you have commercial insurance. A Companion in Care can help you determine which of the following offers is best for you based on your drug insurance coverage.

Governmental beneficiaries excluded; subject to terms and conditions.

Sign up for savings

To get your savings card, we need your HIPAA authorization to work on your behalf to ensure you’re paying as little as $5 or $25 a month.

As a reminder, HIPAA is the Health Insurance Portability and Accountability Act that provides data privacy and security to protect your medical information.

Pay As Little As

$5 If Olumiant is covered by commercial drug insurance

$5 if Olumiant is covered by commercial drug insurance

If you have commercial insurance with a plan that covers Olumiant, you may be eligible to pay as little as a $5 co-pay for a 30-day supply each time you fill your prescription.*

$25 If Olumiant is not covered by commercial drug insurance

$25 if Olumiant is not covered by commercial drug insurance

If you have commercial insurance with a plan that does not cover Olumiant, you may be eligible to pay as little as $25 for a 30-day supply.*

Are you eligible for savings?

To find out, call Olumiant Together at 1-844-OLUMIANT (1-844-658-6426) Monday - Friday between 8 AM and 10 PM ET. A Companion in Care will be able to answer your questions.

*Terms and Conditions:
This Card expires on 12/31/2024. Patients must first use their card by 12/31/2021 and are eligible for savings for up to 36 months of therapy, provided they continue to meet program terms and conditions. Patient must have coverage for Olumiant with their commercial drug insurance to pay as little as $5 monthly for a 30-day supply of Olumiant, subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate $12,000 maximum annual cap. Patients with commercial drug insurance that are denied coverage after a prior authorization (PA) for Olumiant may be eligible to pay as low as $25 monthly for a 30-day supply, subject to monthly and annual cap of wholesale acquisition cost plus usual and customary pharmacy charges. Continued participation in $25 monthly program requires appeal submission and decision within 6 months post program initiation and a new PA or medical exception (ME) every 12 months, to verify coverage status and potential eligibility for the $5 monthly program. Participation in the program requires a valid patient HIPAA authorization. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for patients without commercial drug insurance or those whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found here.

PURPOSE AND SAFETY SUMMARY WITH WARNINGS
PURPOSE AND SAFETY SUMMARY WITH WARNINGS

Important Facts About Olumiant® (O-loo-mē·ant). It is also known as baricitinib.

 

Olumiant is a prescription medicine used to treat adults with moderately to severely active rheumatoid arthritis (RA) who have tried at least one other medicine called a tumor necrosis factor (TNF) antagonist that did not work well enough or could not be tolerated. The medicine comes in a tablet and is taken orally.

WARNINGS
Olumiant may cause serious side effects. Some people who have taken Olumiant have had:

  • Serious infections, including tuberculosis (TB), shingles, and others caused by bacteria, fungi, or viruses. Some people have died from these infections. Olumiant can make you more likely to get infections or make them worse. Your doctor should test for TB before starting Olumiant and watch for TB symptoms during treatment. You should not start Olumiant if you have any kind of infection unless your doctor tells you it is okay. While taking Olumiant, tell your doctor right away if you have symptoms of an infection, such as:

    • fever, sweating, or chills
    • muscle aches
    • cough
    • shortness of breath
    • blood in phlegm
    • weight loss
    • warm, red, or painful skin or sores on your body
    • diarrhea or stomach pain
    • burning with urination or urinating more often than normal
    • feeling tired
  • Cancer and immune system problems. Olumiant may increase your risk of lymphoma and other cancers, including skin cancers.
  • Blood clots in the veins of your legs or lungs. This may be life-threatening and cause death. While taking Olumiant, tell your doctor right away if you have any signs and symptoms of blood clots, including swelling, pain or tenderness in the leg, sudden chest pain, or shortness of breath.
  • Tears in the stomach or intestines. This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or methotrexate. While taking Olumiant, tell your doctor right away if you have fever and stomach-area pain that does not go away, and a change in bowel habits.
  • Changes in laboratory test results. Your doctor should do blood tests to check your white and red blood cells before and while you are taking Olumiant. Your doctor should also check certain liver tests. You should not take Olumiant if your blood cell counts are too low or your liver tests are too high. If your results change, your doctor may pause your treatment with Olumiant. Your doctor should also check your cholesterol approximately 12 weeks after you start this medicine and as needed after that.
COMMON SIDE EFFECTS

The most common side effects of Olumiant include:

  • upper respiratory tract infections, such as a cold or sinus infections
  • nausea
  • cold sores
  • shingles

These are not all the possible side effects of Olumiant. Tell your doctor if you have any side effects. You can report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

BEFORE USING

Before you use Olumiant, tell your doctor if you:

  • Are being treated for an infection, have an infection that won’t go away or keeps coming back, or think you have symptoms of an infection.
  • Have TB or have been in close contact with someone with TB.
  • Have had hepatitis B or C, cancer, or blood clots in the veins of your legs or lungs.
  • Live, have lived, or have visited parts of the country that increase your risk of fungal infections. These may include the Ohio and Mississippi River valleys and the Southwest. Ask your doctor if you do not know if you have lived in an area where these infections are common.
  • Have other medical conditions, including kidney or liver problems, low blood cell counts, diabetes, lung disease, HIV, or a weak immune system.
  • Have any stomach-area pain or have been diagnosed with inflammation in the large intestine or ulcers in your stomach or intestines.
  • Have recently received or plan to receive a vaccine. People taking Olumiant should not receive live vaccines.
  • Are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. You should not take Olumiant and breastfeed.

  • Are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your doctor, if you take a medicine called probenecid or any other medicines to treat rheumatoid arthritis. For example, you should not take any of the following medicines while taking Olumiant since this may increase your risk of infection:


    • tocilizumab (Actemra®)
    • etanercept (Enbrel®)
    • adalimumab (Humira®)
    • infliximab (Remicade®)
    • rituximab (Rituxan®)
    • abatacept (Orencia®)
    • anakinra (Kineret®)
    • certolizumab pegol (Cimzia®)
    • golimumab (Simponi®)
    • tofacitinib (Xeljanz®/Xeljanz XR®)
    • sarilumab (Kevzara®)
    • azathioprine or cyclosporine
  • Are under age 18. It is not known if Olumiant is safe and effective in children.
HOW TO TAKE
  • Take Olumiant exactly as your doctor says.
  • Take Olumiant once a day with or without food.
LEARN MORE

For more information, call 1-800-545-5979.

This summary provides basic information about Olumiant but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about Olumiant and how to take it. Your doctor is the best person to help you decide if Olumiant is right for you.


Olumiant® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. All other product names and trademarks are the property of their respective trademark owners.

BA CON BS 01JUL2019

Please click to access full Prescribing Information, including Boxed Warning about Serious Infections, Malignancies, and Thrombosis, and Medication Guide.

Are you a US healthcare provider?

The information contained in this section of olumiant.com is intended for US healthcare providers. Please confirm below.

Are you a US payer representative?

The information contained in this section of olumiant.com is intended for US payer representatives. Please confirm below.

You are now leaving olumiant.com.

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

Click “Continue” to leave site or “Return to olumiant.com” to close this window and return to olumiant.com.

*Terms and Conditions:

*By using the Olumiant Savings Card (“Card”), you attest that you meet the eligibility criteria, agree to, and will comply with the Terms and Conditions described below:
This Card expires on 12/31/2024. Patients must first use their card by 12/31/2021 and are eligible for savings for up to 36 months of therapy, provided they continue to meet program terms and conditions. Patient must have coverage for Olumiant with their commercial drug insurance to pay as little as $5 monthly for a 30-day supply of Olumiant, subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate $12,000 maximum annual cap. Patient must have commercial drug insurance, diagnosis consistent with FDA approved product labeling, insurance provider denied coverage, and a denied prior authorization (PA) for Olumiant to pay as little as $25 monthly for a 30-day supply of Olumiant, subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges. Continued participation in $25 monthly program requires appeal submission and decision within 6 months post program initiation and a new PA or medical exception (ME) every 12 months, to verify coverage status and potential eligibility for the $5 monthly program. Participation in the program requires a valid patient HIPAA authorization. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps.

Offer void where prohibited by law. This offer is invalid for patients without commercial drug insurance or those whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. If you live in Massachusetts, the Card expires on the earlier of: (i) the expiration date of this Card (12/31/2024); (ii) the date an AB-rated generic equivalent for Olumiant becomes available; or (iii) [12/31/2020], absent a change in Massachusetts state law. If you live in California, the Card expires on the earlier of: (i) the expiration date of this Card 12/31/2024 or (ii) the date an FDA-approved therapeutically equivalent for Olumiant or over-the-counter product with the same active ingredients becomes available. Available only in the US and Puerto Rico for residents of the US and Puerto Rico. By accepting this offer, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you should notify your insurance carrier of your redemption of this Card. This offer cannot be combined with any other program, discount, discount card, cash discount card, incentive, or similar offer involving Olumiant. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade; or to counterfeit this Card. This offer may be terminated, rescinded, revoked, or amended by Lilly USA, LLC, at any time without notice. This Card is not health insurance. This Card expires on 12/31/2024.